ArticlePloS one2020

Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older.

Ja Seo Koo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.